3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow CPI-1205: new trials by email Literature Review of CPI-1205 trials Research Report on CPI-1205
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors CPI-1205, ipilimumab - Advanced Solid Tumors | Phase 1 | Completed | Constellation Pharmaceuticals | 24 | 2017-12-14 | 2022-05-18 |
| ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer CPI-1205, Cobicistat, Enzalutamide - Metastatic Castration Resistant Prostate Cancer (mCRPC) | Phase 1 / Phase 2 | Completed | Constellation Pharmaceuticals | 175 | 2017-11-15 | 2025-10-29 |
| A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas CPI-1205 - B-Cell Lymphoma | Phase 1 | Completed | Constellation Pharmaceuticals | 41 | 2015-03-01 | 2022-05-18 |
Neoplasms (2) · Lymphoma, B-Cell (1)
Constellation Pharmaceuticals (3)
United States (3)